Albers Jeffrey W. - Insider Transactions
Insider Type
individual
Companies
3
Average
2,768,454
Total Txns
42
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 8 | -8 | 0.00 | 2,362,769.78 | -2,362,769.78 |
| 2024 | 0 | 23 | -23 | 0.00 | 9,777,631.18 | -9,777,631.18 |
| 2025 | 0 | 11 | -11 | 0.00 | 4,470,325.01 | -4,470,325.01 |
| Total: | 0 | 42 | 10 | 0.00 | 16,610,725.97 | -16,610,725.97 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
49.00 USD |
6,349 Sold |
311,101 USD |
03/06/2025 | 03/06/2025 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
49.00 USD |
6,349 Sold |
311,101 USD |
03/06/2025 | 03/06/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
101.02 USD |
4,350 Sold |
439,437 USD |
27/05/2025 | 27/05/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
101.93 USD |
650 Sold |
66,255 USD |
27/05/2025 | 27/05/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
88.37 USD |
1,800 Sold |
159,066 USD |
12/03/2025 | 12/03/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
87.62 USD |
5,700 Sold |
499,434 USD |
12/03/2025 | 12/03/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
88.80 USD |
5,766 Sold |
512,021 USD |
05/03/2025 | 05/03/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
109.11 USD |
7,561 Sold |
824,981 USD |
21/01/2025 | 21/01/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
109.92 USD |
7,400 Sold |
813,408 USD |
21/01/2025 | 21/01/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
110.61 USD |
200 Sold |
22,122 USD |
21/01/2025 | 21/01/2025 |